Real-life, long-term data on efficacy, safety, response and discontinuation patterns of omalizumab in a Greek population with chronic spontaneous urticaria

被引：0
|
作者：
Zoe Apalla
Theodoros Sidiropoulos
Evaggelia Kampouropoulou
Marina Papageorgiou
Aimilios Lallas
Elizabeth Lazaridou
Maria Smaragdi
Florentina Delli
机构：
[1] Hippokratio General Hospital of Thessaloniki,State Dermatology Department
[2] Aristotle University of Thessaloniki,First Dermatology Department
[3] Aristotle University of Thessaloniki,Second Dermatology Department
来源：
European Journal of Dermatology | 2020年 / 30卷
关键词：
chronic spontaneous urticaria; urticaria; omalizumab; angioedema; allergy; IgE inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：716 / 722
页数：6
相关论文
共 50 条
  • [31] Long-term efficacy of omalizumab in seven patients with treatment-resistant chronic spontaneous urticaria
    Silva, P. M.
    Costa, A. C.
    Mendes, A.
    Barbosa, M. P.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2015, 43 (02) : 168 - 173
  • [32] Omalizumab in chronic spontaneous urticaria A real-life experience of dose and intervals adjustments in Belgium
    de Montjoye, Laurence
    Herman, Anne
    Dumoutier, Laure
    Lambert, Michel
    Tromme, Isabelle
    Baeck, Marie
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : 620 - 622
  • [33] The use of Omalizumab in Severe Allergic Asthma and Chronic Spontaneous Urticaria: real-life experience
    Irani, Carla
    Hallit, Souheil
    Daccache, Stephanie
    Salameh, Pascale
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB34 - AB34
  • [34] Omalizumab in chronic urticaria; real-life data of 6-year-experience
    Ozdemir, Adem
    Bilgic, Asli
    Koyuncu, Mehmet Ali
    Yilmaz, Ertan
    TURK DERMATOLOJI DERGISI-TURKISH JOURNAL OF DERMATOLOGY, 2021, 15 (03): : 66 - 73
  • [35] Comparison of long-term safety and efficacy of omalizumab in chronic urticaria: 9 year retrospective study
    Marcelino, J.
    Costa, A. C.
    Silva, P.
    Mendes, A.
    Alonso, E.
    Duarte, F.
    Aguiar, P.
    Pedro, E.
    Pereira Barbosa, M.
    ALLERGY, 2016, 71 : 558 - 558
  • [36] Retrospective Analysis of Successful Discontinuation of Long-Term Omalizumab Therapy in Patients with Chronic Urticaria
    Everist, Brynn
    Love, Marissa
    Hu, Jinxiang
    Khan, Sadia Hayat
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB33 - AB33
  • [37] Omalizumab chronic spontaneous urticaria Efficacy, safety, predictors of treatment outcome, and time to response
    Nettis, Eustachio
    Cegolon, Luca
    Di Leo, Elisabetta
    Rizzini, Fabio Lodi
    Detoraki, Aikaterini
    Canonica, Giorgio Walter
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (04) : 474 - 478
  • [38] Long-Term Omalizumab Use, Chronic Spontaneous Urticaria and COVID-19
    Ozdemir, Oner
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2024, 14 (01):
  • [39] Analysis of the long-term economic burden of omalizumab on patients with chronic spontaneous urticaria
    Matsubara, Daiki
    Takahagi, Shunsuke
    Saito, Ryo
    Kamegashira, Akiko
    Tanaka, Akio
    Hide, Michihiro
    JOURNAL OF DERMATOLOGY, 2021, 48 (01): : 56 - 63
  • [40] Long term (>1 year) treatment of chronic spontaneous urticaria with Omalizumab-A real life study
    Asher, I
    Magen, E.
    Vaddas, Z.
    Tubi, E.
    Mahlab, Guri K.
    Sthoeger, Z.
    ALLERGY, 2020, 75 : 196 - 196
12345